Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. (Q45996174)
Jump to navigation
Jump to search
scientific article published on 7 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. |
scientific article published on 7 December 2012 |
Statements
1 reference
Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. (English)
1 reference
Y Ishibashi
1 reference
T Matsui
1 reference
M Takeuchi
1 reference
S Yamagishi
1 reference
7 December 2012
1 reference
1 reference
45
1 reference
387-390
1 reference
5
1 reference
Identifiers
1 reference
1 reference